Literature DB >> 16606970

Axillary sentinel lymph nodes can be falsely positive due to iatrogenic displacement and transport of benign epithelial cells in patients with breast carcinoma.

Ira J Bleiweiss1, Chandandeep S Nagi, Shabnam Jaffer.   

Abstract

PURPOSE: Immunohistochemical (IHC) staining for cytokeratins (CK) is common practice in evaluating sentinel lymph nodes (SLNs) in patients with breast carcinoma. IHC positivity typically indicates metastasis. SLN procedures are increasingly common in patients with pure intraductal carcinoma (DCIS). Iatrogenic epithelial cell displacement and benign transport of breast epithelial cells into axillary lymph nodes are recently described phenomena. We report 25 cases in which these factors probably resulted in benign epithelial cells in axillary SLNs (ie, false positivity).
METHODS: We reviewed 25 cases of CK-positive SLNs in which the epithelial cells had histologic and IHC characteristics different from their respective patients' underlying breast carcinomas.
RESULTS: In all cases, the cytologic features of the epithelial cells in the SLNs were benign, and 22 matched those of corresponding intraductal papillomas that were involved by or were separate from the DCIS in the original cores or surgical biopsies. Fifteen cases were pure DCIS; most invasive tumors were smaller than 1.0 cm. In six carcinomas (DCIS) showing strong Her-2/neu staining, the corresponding epithelial cells in the SLNs were negative. In 13 tumors that were strongly and uniformly positive for estrogen receptor (ER), the cytokeratin-positive cells in the SLNs were negative for ER. Nineteen cases showed benign epithelial cell displacement at the biopsy site.
CONCLUSION: Epithelial cells in SLNs may result from transport of displaced cells, usually originating in intraductal papillomas. Positive immunohistochemical results in SLNs should be interpreted with extreme caution to avoid automatically concluding that such cells represent metastasis. Sentinel lymph nodes in breast carcinoma can be falsely positive.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16606970     DOI: 10.1200/JCO.2005.04.7076

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  19 in total

Review 1.  Minimal disease in sentinel nodes.

Authors:  Gábor Cserni
Journal:  Pathol Oncol Res       Date:  2008-05-21       Impact factor: 3.201

2.  Real-Time qPCR-Based Detection of Circulating Tumor Cells from Blood Samples of Adjuvant Breast Cancer Patients: A Preliminary Study.

Authors:  Ulrich Andergassen; Michael Zebisch; Alexandra C Kölbl; Alexander König; Sabine Heublein; Lennard Schröder; Stefan Hutter; Klaus Friese; Udo Jeschke
Journal:  Breast Care (Basel)       Date:  2016-06-15       Impact factor: 2.860

Review 3.  Sentinel lymph node biopsy under local anesthesia in patients with breast cancer.

Authors:  Prakasit Chirappapha; Visnu Lohsiriwat; Youwanush Kongdan; Panuwat Lertsithichai; Thongchai Sukarayothin; Chairat Supsamutchai; Nina Talakhadze; Stefano Zurrida
Journal:  Gland Surg       Date:  2012-11

4.  Sentinel lymph node biopsy in staging small (up to 15 mm) breast carcinomas. Results from a European multi-institutional study.

Authors:  Gábor Cserni; Simonetta Bianchi; Vania Vezzosi; Riccardo Arisio; Rita Bori; Johannes L Peterse; Anna Sapino; Isabella Castellano; Maria Drijkoningen; Janina Kulka; Vincenzo Eusebi; Maria P Foschini; Jean-Pierre Bellocq; Cristi Marin; Sten Thorstenson; Isabel Amendoeira; Angelika Reiner-Concin; Thomas Decker; Manuela Lacerda; Paulo Figueiredo; Gábor Fejes
Journal:  Pathol Oncol Res       Date:  2007-03-27       Impact factor: 3.201

Review 5.  Sentinel lymph node biopsy and management of the axilla in ductal carcinoma in situ.

Authors:  Hilary M Shapiro-Wright; Thomas B Julian
Journal:  J Natl Cancer Inst Monogr       Date:  2010

6.  Histopathological growth distribution of ductal carcinoma in situ: tumor size is not "one size fits all".

Authors:  Thomas J O'Keefe; Olivier Harismendy; Anne M Wallace
Journal:  Gland Surg       Date:  2022-02

7.  Lymphovascular invasion and lobular histology are associated with increased incidence of isolated tumor cells in sentinel lymph nodes from early-stage breast cancer patients.

Authors:  Elizabeth A Mittendorf; Aysegul A Sahin; Susan L Tucker; Funda Meric-Bernstam; Min Yi; Khazi M Nayeemuddin; Gildy V Babiera; Merrick I Ross; Barry W Feig; Henry M Kuerer; Kelly K Hunt
Journal:  Ann Surg Oncol       Date:  2008-09-25       Impact factor: 5.344

8.  Promoter hypermethylation in sentinel lymph nodes as a marker for breast cancer recurrence.

Authors:  Hetty E Carraway; Shelun Wang; Amanda Blackford; Mingzho Guo; Penny Powers; Stacie Jeter; Nancy E Davidson; Pedram Argani; Kyle Terrell; James G Herman; Julie R Lange
Journal:  Breast Cancer Res Treat       Date:  2008-04-11       Impact factor: 4.872

9.  Ductal carcinoma in situ and sentinel lymph node metastasis in breast cancer.

Authors:  Keiichiro Tada; Akiko Ogiya; Kiyomi Kimura; Hidetomo Morizono; Kotaro Iijima; Yumi Miyagi; Seiichiro Nishimura; Masujiro Makita; Rie Horii; Futoshi Akiyama; Takuji Iwase
Journal:  World J Surg Oncol       Date:  2010-01-27       Impact factor: 2.754

10.  A Rapidly Enlarging Squamous Inclusion Cyst in an Axillary Lymph Node following Core Needle Biopsy.

Authors:  Cunxian Zhang; Jinjun Xiong; M Ruhul Quddus; Joyce J Ou; Katrine Hansen; C James Sung
Journal:  Case Rep Pathol       Date:  2012-04-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.